Alcon AG | ALC - Sales Revenues

Stock Price
66.76
Daily Change
-0.30 -0.45%
Monthly
7.71%
Yearly
-19.57%
Q1 Forecast
62.72

Alcon AG reported $2.7B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Bayer EUR 9.66B 1.08B Sep/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Smith & Nephew USD 2.96B 134M Dec/2025
Sonova Holding CHF 1.82B 216.8M Dec/2025
UCB EUR 3.49B 129M Jun/2025